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ABSTRACT
The vascular endothelial growth factor (VEGFA, VEGF) regulates
neurovascular patterning. Alternative splicing of theVegfa gene gives
rise to threemajor isoforms termed VEGF121, VEGF165 and VEGF189.
VEGF165 binds the transmembrane protein neuropilin 1 (NRP1)
and promotes the migration, survival and axon guidance of subsets
of neurons, whereas VEGF121 cannot activate NRP1-dependent
neuronal responses. By contrast, the role of VEGF189 in NRP1-
mediated signalling pathways has not yet been examined. Here, we
have combined expression studies and in situ ligand-binding assays
with the analysis of genetically altered mice and in vitro models to
demonstrate that VEGF189 can bind NRP1 and promote NRP1-
dependent neuronal responses.
KEY WORDS: Vascular endothelial growth factor (VEGF), VEGF189,
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INTRODUCTION
Vascular endothelial growth factor A (VEGFA, VEGF) is a potent
inducer of blood vessel growth, but also has essential roles in
neurodevelopment (Mackenzie and Ruhrberg, 2012). In humans,
VEGF is encoded by a single gene (VEGFA) of eight exons that is
alternatively spliced into isoforms, the major ones containing 121,
165 and 189 amino acid residues and therefore termed VEGF121,
VEGF165 and VEGF189, respectively (Fig. 1A; Koch et al., 2011).
The alternatively spliced exons 6 and 7 encode domains that enable
extracellular matrix (ECM) binding and additionally mediate
differential binding to VEGF receptors. All VEGF isoforms bind
the receptor tyrosine kinases VEGFR1 (FLT1) and VEGFR2 (KDR,
FLK1), whereas the non-catalytic receptors neuropilin (NRP) 1 and
NRP2 are VEGF isoform-specific receptors that preferentially bind
VEGF165 over VEGF121 (Fig. 1A; Gluzman-Poltorak et al., 2000;
Soker et al., 1998). Unexpectedly, recent studies showed that VEGF
binding to NRP1 is largely dispensable for embryonic angiogenesis
(Fantin et al., 2014). By contrast, VEGF signalling through NRP1
has multiple roles in neurodevelopment, including guiding
migrating facial branchiomotor (FBM) neurons in the hindbrain
(Schwarz et al., 2004), promoting the survival of migrating
gonadotropin-releasing hormone (GnRH) neurons (Cariboni et al.,
2011) and enhancing the contralateral projection of retinal ganglion
cell (RGC) axons across the optic chiasm (Erskine et al., 2011).
To demonstrate roles for VEGF binding to NRP1 in neurons,
prior studies used Vegfa120/120 mice, which express VEGF120, the
murine equivalent of VEGF121, but lack VEGF164 and VEGF188,
corresponding to human VEGF165 and VEGF189, respectively
(Carmeliet et al., 1999). Vegfa120/120mice phenocopy the defects of
NRP1 knockouts in FBM neuron migration, GnRH neuron survival
and RGC axon guidance (Cariboni et al., 2011; Erskine et al., 2011;
Schwarz et al., 2004). In all three systems, VEGF signalling was
attributed to the activity of VEGF165 because it evokes appropriate
neuronal responses in tissue culture models (Cariboni et al., 2011;
Erskine et al., 2011; Schwarz et al., 2004), and because the ability of
NRP1 to bind VEGF165 is well established (Fantin et al., 2014;
Soker et al., 1998). However, Vegfa120/120mutants lack VEGF188 in
addition to VEGF164. Yet, it has never previously been examined
whether VEGF189 can also function as a NRP1 ligand in vivo.
Moreover, it is not known whether VEGF121 can bind NRP1 in a
physiologically relevant context, even though it has been suggested
that the exon 8 domain, which is present in all major VEGF
isoforms, including VEGF121, can mediate NRP1 binding in vitro
(Jia et al., 2006; Pan et al., 2007; Parker et al., 2012).
Here, we have generated alkaline phosphatase (AP)-conjugated
VEGF isoforms for in situ ligand-binding assays (Fantin et al., 2014)
to examine whether VEGF121 or VEGF189 can bind NRP1 in vivo, as
previously reported for VEGF165. Our studies demonstrate that
VEGF189 binds NRP1-expressing axon tracts in intact hindbrain
tissue, but that VEGF121 is unable to do so. We further show that
VEGF188 is co-expressed with the other isoforms during VEGF/
NRP1-dependent FBM migration, GnRH neuron survival and RGC
axon guidance, and that VEGF188 is sufficient to control all three
processes, whereas VEGF120 is not. We conclude that VEGF188
effectively binds NRP1 and has the capacity to evoke NRP1-
dependent signalling events, similar to VEGF164. Considering that
VEGF189 has the highest affinity for ECM and therefore tissue
retention amongst the VEGF isoforms, future research may therefore
wish to consider the mechanistic contribution and therapeutic
potential of this understudied VEGF isoform.
RESULTS AND DISCUSSION
VEGF188 is co-expressed with VEGF120 and VEGF164 in
developing hindbrain, nose and diencephalon, and binds
axons in a NRP1-dependent fashion
Because prior studies implicated VEGF signalling through NRP1 in
FBM neuron migration in the hindbrain, GnRH neuron survival in
the nose and RGC axon guidance in the diencephalon (Cariboni
et al., 2011; Erskine et al., 2011; Schwarz et al., 2004), we asked
which Vegfa isoforms were expressed in these developmental
contexts. For this experiment, we designed isoform-specific primers
that can distinguish the Vegfa120, Vegfa164 and Vegfa188 mRNAReceived 1 August 2014; Accepted 26 November 2014
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species by reverse transcription (RT)-PCR (Fig. 1A,B;
supplementary material Fig. S1A). This analysis demonstrated that
all three isoforms were co-expressed during relevant periods of
VEGF/NRP1-dependent neurodevelopment in mice (Fig. 1C).
Because prior studies ofVEGFbinding toNRP1have not examined
whether VEGF189 or VEGF121 can bind NRP1 in vivo, we used the
mouse hindbrain as a physiologically relevant model to compare the
ability of the three major VEGF isoforms to bind NRP1 in a tissue
context.We first performed immunostaining with a validated antibody
for NRP1 (Fantin et al., 2010) to confirm that NRP1 localises to blood
vessels in wild-type, but not NRP1 knockout, hindbrains (Fig. 1D;
note unspecific staining of blood in the dilated vessels of mutants).
Immunolabelling also confirmed NRP1 expression in TUJ1-positive
dorsolateral axons on the pial side of wild-type, but not mutant,
hindbrains (Fig. 1D; supplementary material Fig. S1B). Nrp1−/−
hindbrains showed some defasciculation of these dorsolateral axons,
but they were still clearly present in the mutant, suggesting that this are
a suitable model to examine VEGFA isoform binding to NRP1.
To compare the binding properties of VEGF121, VEGF165 and
VEGF189, we fused each isoform to AP and performed in situ ligand
binding assays on E12.5 hindbrains. As expected, all three isoforms
bound vessels (Fig. 1E), because they express the pan-VEGF isoform
receptorVEGFR2 (Lanahan et al., 2013).Wenext examined binding to
dorsolateral axons, because they express NRP1, but lack VEGFR2
(Lanahan et al., 2013). Both VEGF165 and VEGF189 bound these
axons,whereasVEGF121 did not (Fig. 1E). These observations indicate
that all VEGF isoforms are capable of binding VEGFR2/NRP1-
positive vessels. By contrast, only VEGF165 and VEGF189, but not
VEGF121, boundNRP1-expressing axons lackingVEGFR2, consistent
with the previously reported 10-fold lower affinity of VEGF121 for
NRP1 in vitro (Parker et al., 2012). The finding that VEGF121 does not
bind endogenous neuronal NRP1 at detectable levels also agrees with
prior genetic studies, which showed that VEGF120 is unable to
compensate for VEGF164 in FBM, RGC andGnRH neurons (Cariboni
et al., 2011; Erskine et al., 2011; Schwarz et al., 2004). Thus, low-
affinity binding of VEGF121 to NRP1, even though previously
observed in vitro, is unlikely to be relevant in vivo, at least in a
neuronal context.
We next confirmed that axonal VEGF189 binding is NRP1
dependent. The AP ligand-binding assay showed that VEGF189
bound vessels (Fig. 1F) in Nrp1-null mutant hindbrains with their
characteristic vascular tufts (Fantin et al., 2013a). Strikingly, AP-
VEGF189 failed to bind axons in Nrp1-null hindbrains, similar to
AP-VEGF165 (Fig. 1F). VEGF189 can therefore bind axons in a
Fig. 1. VEGF189 is expressed indevelopingmouse tissues andbindsNRP1 in the developing hindbrain. (A) Current knowledge of VEGF isoformbinding to their
receptors. All isoforms bind VEGFR1/2, whereas only VEGF165 is known to bind NRP1. VEGF121 can bind NRP1 with low affinity in vitro, but whether this association
occurs in vivo has not been shown. Moreover, it has not been shown whether VEGF189 binds NRP1 in vivo. Red arrows below each isoform indicate the position of
oligonucleotide primers used for RT-PCR in B. (B)Vegfa isoform-specific oligonucleotide primers for RT-PCRwere validatedwith pBlueScript vectors (pBS) containing
mouse Vegfa120, Vegfa164 or Vegfa188 cDNA, respectively. (C) RT-PCR analysis of the indicated tissues shows that Vegfa120 (179 bp), Vegfa164 (159 bp) and
Vegfa188 (215 bp) are co-expressed. (D)Whole-mount staining of E12.5wild-typehindbrains forNRP1andTUJ1 togetherwith IB4; singleNRP1channelsare shown in
grey scale adjacent to each panel. The white arrows indicate IB4-positive vessels; the arrowhead indicates nonspecific NRP1 staining of blood cells inside mutant
vessels; the red wavy arrows indicate TUJ1-positive axons; open triangles indicate absent NRP1 staining in subventricular plexus (SVP) vessels and pial axons. Scale
bar: 200 μm. (E,F) AP-VEGF121, AP-VEGF165 and AP-VEGF189 binding to E12.5 wild-type hindbrains (E) and AP-VEGF189 binding to E12.5 Nrp1
−/− and Nrp2−/−
hindbrains (F).Thewhitearrows indicateVEGFbinding tovessels; the redwavyarrows indicatebinding toaxons; theopen triangles indicateabsenceofVEGF121binding
to wild-type axons in E and absence of VEGF189 binding to axons in Nrp1
−/− hindbrains in F. The arrowhead indicates vascular tufts. Scale bars: 25 μm.
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NRP1-dependent fashion. By contrast, loss of NRP2 (Giger et al.,
2000) did not abolish VEGF189 binding (Fig. 1F). Taken together, the
ligand binding assays of intact hindbrain tissue show that NRP1 serves
as a neuronal receptor forVEGF165 andVEGF189, but not forVEGF121.
VEGF188 is sufficient for the NRP1-dependent migration of
FBM neurons
Vegfa is a haploinsufficient gene for which deletion of just one allele
results in early embryonic lethality due to a complete failure of blood
vessel formation (Carmeliet et al., 1996; Ferrara et al., 1996).
However, retention of any one of the major VEGF isoforms rescues
this severe phenotype and instead gives rise to more subtle neuronal
and vascular phenotypes (Ruhrberg et al., 2002; Stalmans et al.,
2002). Understanding the receptor-binding properties of the VEGF
isoforms has therefore become a priority in the field. We first
examined if VEGF188 can substitute for VEGF164 in FBM neuron
guidance with an established hindbrain explant assay in which
implanted beads provide exogenous VEGF, and FBM neuron
migration is visualised by immunolabelling with the motor neuron
marker ISL1 (Schwarz et al., 2004; Tillo et al., 2014). Agreeing with
previous observations, FBM neurons were attracted to VEGF164, but
not to control beads lacking growth factors (Fig. 2B). VEGF188 beads
also attracted FBM neurons (Fig. 2B). Quantification confirmed that
FBM neuron migration was significantly enhanced on the hindbrain
side containing a VEGF164- or VEGF188-soaked bead relative to the
control side of the same hindbrain (Fig. 2C). VEGF188 can therefore
promote NRP1-dependent neuronal migration similar to VEGF164.
We next examined FBM neuron migration in vivo by Isl1
in situ hybridisation. As previously shown (Schwarz et al., 2004),
Vegfa120/120 hindbrains demonstrated abnormal streaming of FBM
neurons on theventricular side anddumbbell-shapednuclei on the pial
side (Fig. 2D). By contrast, Vegfa188/188 mice, which express only
VEGF188, showed normal FBM neuron migration (Fig. 2D).
Moreover, replacing one Vegfa120 allele in Vegfa120/120 mutants
with the Vegfa188 allelewas sufficient to prevent FBM neuron defects
(Fig. 2D). Unlike VEGF120, VEGF188 is therefore sufficient to direct
NRP1-dependent neuronal migration.
VEGF188 is sufficient to guide NRP1-dependent axon
crossing at the optic chiasm
Wenext investigatedwhether VEGF188 can evoke neuronal responses
similar to VEGF164 in the developing visual system. To establish
binocular vision, RGC axons project through the optic chiasm to both
the ipsilateral and contralateral brain hemispheres (Erskine and
Herrera, 2007). VEGF164, but not VEGF120, promotes RGC axon
guidance in aNRP1-dependent fashion in vitro, andVegfa120/120mice
therefore develop an abnormal chiasm (Erskine et al., 2011). To
examinewhether VEGF188 can also promote RGC axon guidance, we
performed DiI labelling in VEGF isoform mutants. Anterograde
labelling of RGC axons from one eye at E14.5 demonstrated that
VEGF188 was sufficient for NRP1-mediated chiasm patterning
(Fig. 3A). Thus, Vegfa120/120 mice had a significantly increased
ipsilateral projection index as well as defasciculation of the ipsilateral
and contralateral optic tracts (Erskine et al., 2011), but the ipsilateral
index and shapeof the optic chiasmappearedunaffected inVegfa188/188
mice (Fig. 3B,C). Moreover, replacing one Vegfa120with the Vegfa188
allele was sufficient to prevent chiasm defects in Vegfa120/120 mutants
(Fig. 3B,C).
Fig. 2. VEGF188 is sufficient for FBM neuron migration. (A) Schematic representation of FBM neuron migration in the mouse. (B) ISL1 staining of E12.5
hindbrain explants containing implanted heparin beads soaked in PBS (n=10) or PBS containing VEGF164 (n=10) or VEGF188 (n=6). Red dotted circles indicate
the position of heparin beads; white arrowheads indicate normal migration; red arrows indicate migration towards heparin beads; asterisks indicate the midline.
Scale bar: 200 µm. (C) Distance migrated by FBM neurons. Migration distancewas quantified as migration away from r5 territory on the hindbrain sidewith a bead
relative to the control half of the same hindbrain; mean±s.e.m. control 1±0.09 versus VEGF164 bead 1.39±0.05; control 1±0.11 versus VEGF188 bead 2.04±0.17;
**P<0.01, VEGF compared with control (t-test). (D) Whole-mount Isl1 in situ hybridisation of E12.5 hindbrains of the indicated genotypes detects migrating FBM
neurons (VIIm) (control, n=10; Vegfa120/120, n=6; Vegfa188/188, n=4; Vegfa120/188, n=5). Brackets indicate the width of the neuronal stream on the ventricular side;
red arrowheads indicate dumbbell-shaped nuclei on the pial side; asterisks indicate the midline. Scale bar: 25 µm.
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We next performed retrograde DiI labelling of RGC axons from
the dorsal thalamus in VEGF isoform mice and compared the
number of labelled RGCs in flatmounted ipsilateral and contralateral
retina (Fig. 3D). Quantitation showed that the proportion of DiI-
labelled ipsilateral RGCs was significantly increased in Vegfa120/120
compared with control mice, but was normal in Vegfa188/188 and
Vegfa120/188 mice (Fig. 3E). Flat-mount images also revealed the
preferential origin of ipsilaterally projecting neurons from the
ventrotemporal retina in wild types (Fig. 3F). Their distribution is
affected in Vegfa120/120 mice, which contain ipsilaterally projecting
RGCs throughout the nasal retina (Erskine et al., 2011), but this
defect was rescued by the introduction of a single Vegfa188 allele
(Fig. 3F). VEGF188 is therefore sufficient to promote NRP1-
dependent aspects of optic chiasm development.
VEGF188 is sufficient to ensure normal GnRH neuron survival
As a third model to study VEGF188 in neurodevelopment, we
investigated GnRH neuron survival. GnRH neurons are born in the
nasal placode and travel along nasal axons to reach the forebrain
(Fig. 4A; Cariboni et al., 2007). We have previously shown that
Vegfa120/120mice have significantly fewer migrating GnRH neurons
and demonstrated that VEGF164 signals through NRP1 to promote
the survival of GN11 cells, which recapitulate many features of
migratory GnRH neurons (Cariboni et al., 2011). We therefore
examined whether VEGF188 promotes GN11 survival, similar to
VEGF164. Whereas 72 h of serum withdrawal caused the death
of over half of the GN11 cells, the inclusion of serum, VEGF164
or VEGF188 for the last 12 h of culture significantly reduced cell
death, and VEGF188 was as effective as VEGF164 in preventing cell
death; by contrast, and as expected, VEGF120 did not promote
survival (Fig. 4B; percentage of propidium iodide-positive cells,
mean±s.e.m.: control, 44±3%; serum, 2±1%; VEGF120, 37±3;
VEGF164, 11±2%; VEGF188, 11±2%). These observations suggest
that VEGF188, similar to VEGF164, can promote GnRH neuron
survival. The ineffectiveness of VEGF120 agreed with the previously
observed NRP1-dependent neuroprotection of GN11 cells and the
Fig. 3. VEGF188 is sufficient to guide commissural axons across the optic chiasm. (A) Schematic illustration of the method used to anterogradely label
RGC projections. DiI crystals were placed onto the retina in one eye to label axons extending through the optic chiasm into the ipsilateral and contralateral optic
tracts. (B) Ipsilateral index in the indicated genotypes (mean±s.e.m.): control, 0.095±0.01, n=11; Vegfa120/120, 0.15±0.03, n=5; Vegfa188/188, 0.083±0.01, n=3;
Vegfa120/188, 0.09±0.01, n=3; t-test, *P<0.05 compared with control. (C) Whole-mount views of RGC axons at the optic chiasm from embryos of the indicated
genotypes, labelled anterogradely with DiI at E14.5; ventral view, anterior upwards; optic nerve (on), contralateral optic tract (otc) and ipsilateral optic tract (oti).
Red arrows indicate the normal position of the ipsilateral projection; red arrowheads indicate the secondary tract and axon defasciculation inVegfa120/120mutants.
Scale bar: 500 µm. Higher magnifications of each boxed areas are shown beneath the respective panels. (D) Schematic illustration of the method used to
retrogradely label RGC projections. DiI crystals were placed unilaterally into the optic tract in the dorsal thalamus. (E) Proportion of ipsilaterally projecting RGCs
relative to total number of RGCs in both eyes of the indicated genotypes at E15.5 (mean±s.e.m.): control, 3.28±0.44%, n=8; Vegfa120/120, 19.64±3.89%, n=4;
Vegfa188/188, 2.16±0.42%, n=4; Vegfa120/188, 2.12±0.14%, n=2; t-test, ***P<0.001 compared with control. (F) Flatmounted ipsilateral retinas from E15.5 embryos
of the indicated genotypes after retrograde labelling from the optic tract in the right thalamus. DT, dorsotemporal; VN, ventronasal; DN, dorsonasal; VT,
ventrotemporal. Scale bar: 500 µm.
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fact that Vegfa120/120 mice have fewer GnRH neurons (Cariboni
et al., 2011). Also in agreement with the in vitro findings, the GnRH
neuron number was normal in Vegfa188/188 mice that express
VEGF188 but lack VEGF164 (Fig. 4C,D). Moreover, replacing one
Vegfa120 allele in Vegfa120/120 mutants with the Vegfa188 allele was
sufficient to prevent their GnRH neuron survival defect (Fig. 4C,D).
Together, these data show that VEGF188 is sufficient to promote
NRP1-dependent neuronal survival.
Conclusions
Our study has demonstrated that human VEGF189, but not VEGF121,
binds NRP1 in a tissue context, that mouse VEGF188 is co-expressed
with VEGF164 in a neuronal context, and that mouse VEGF188
expressed from the endogenous Vegfa locus can evoke NRP1-
dependent neuronal responses in vitro and in vivo, similar to
VEGF164 and unlike VEGF121. Future work on the role of VEGF
signalling through NRP1, especially studies using Vegfa120/120 or
tissue-specific Vegfa-null alleles, should therefore consider the
possibility that VEGF188, similar to VEGF164, can regulate the
process under investigation. This consideration would be relevant for
both neural and vascular studies, or indeed any context inwhichVEGF
signalling through NRP1 is implicated. The finding that the relatively
understudied VEGF189 is capable of evoking VEGF isoform-specific
signalling eventsmayhavebroad implications for the therapeutic use of
VEGF. Thus, VEGF application has been considered in many studies
for pro-angiogenic, pro-neurogenic and neuroprotective therapies, e.g.
the treatment of amyotrophic lateral sclerosis (reviewed by Storkebaum
et al., 2011). Most prior studies have used VEGF165 to ensure
comprehensive receptor targeting; however, the retention of VEGF165
in tissues is inferior to that of VEGF189 due to the presence of only one
instead of two heparin/matrix-binding domains. Our work
demonstrating that VEGF189 is fully capable of engaging NRP1, in
addition to its known ability to bind VEGFR1 and VEGFR2, therefore
suggests that VEGF189 may be better suited than VEGF165 to induce
localised tissue effects in therapeutic applications.
MATERIALS AND METHODS
Animals
Animal procedures were preformed in accordance with institutional and UK
Home Office guidelines. The Vegfa120 and Vegfa188 alleles (Carmeliet et al.,
1999; Stalmans et al., 2002), and Nrp1−/− and Nrp2−/− mice have been
described previously (Giger et al., 2000; Kitsukawa et al., 1997).
RT-PCR and sequencing
Total RNAwas reverse transcribed using Superscript III (Life Technologies)
and Vegfa isoforms amplified by PCR using MegaMix (Microzone) and the
following oligonucleotide pairs: 120-F 5′-GTAACGATGAAGCCCTG-
GAG-3′ and 120-R 5′-CCTTGGCTTGTCACATTTTTC-3′; 164-F 5′-AG-
CCAGAAAATCACTGTGAGC-3′ and 164-R 5′-GCCTTGGCTTGTCA-
CATCT-3′; 188-F 5′-AGTTCGAGGAAAGGGAAAGG-3′ and 188-R
5′-GCCTTGGCTTGTCACATCT-3′.
AP-fusion protein binding assays
Open reading frames for the VEGF isoforms were amplified by PCR with
the oligonucleotides 5′-AATAATGGATCCGCACCCATGGCAGAAGG-
AG-3′ and 5′-TATATGCTCGAGCTCACCGCCTCGGCTTGTC-3′. The
PCR products were cloned into pAG3-AP containing an upstream in-frame
AP cassette. Binding assay were performed as described previously (Fantin
et al., 2013b).
Immunolabelling and in situ hybridisation
Primary antibodies used were: rabbit anti-mouse GnRH (Immunostar,
20075, 1:1000), goat anti-rat NRP1 (R&D Systems, AF566, 1:100), rabbit
anti-mouse TUJ1 (Covance, MRB-435p, 1:250) and mouse anti-rat ISL1
(DSHB, 39.4D5, 1:100). Secondary antibodies used were: Alexa594-
conjugated rabbit anti-goat Fab (Jackson ImmunoResearch, 305-587-003,
1:200), Alexa488-conjugated donkey anti-rabbit Fab (Jackson
ImmunoResearch, 711-547-003, 1:200), Alexa488-conjugated
goat anti-mouse (Life Technologies, A-110011, 1:200) and
biotinylated goat anti-rabbit (Vector Laboratories, BA-1000,
1:200). To detect blood vessels, we used biotinylated IB4 (Sigma)
followed by Alexa633-conjugated streptavidin (Life Technologies).
For in situ hybridisation, we used a digoxigenin-labelled Isl1 probe
(Schwarz et al., 2004).
Fig. 4. VEGF188 is sufficient to promote GnRH neuron survival. (A) GnRH neuron migration (blue dots). The neurons are born in the nasal placodes
that give rise to the olfactory and vomeronasal epithelia (OE, VNO) and migrate along olfactory and vomeronasal axons (purple, Olf/VN) through the
nasal compartment (NC) to reach the forebrain (FB). (B) Serum-starved GN11 cells were treated with DMEM or DMEM-containing serum, VEGF120,
VEGF164 or VEGF188; cell death was visualised by propidium iodide staining (red); Hoechst staining (blue) identified the total number of cells. Scale bar:
25 µm. (C) Sagittal sections of E14.5 mouse heads of the indicated genotypes, immunolabelled for GnRH. Arrows indicate migrating neurons;
arrowheads indicate blood vessels; open triangles indicate the absence of migrating neurons; dotted lines indicate the FB boundary. OB, olfactory bulb.
Scale bar: 100 µm. (D) GnRH neuron number in E14.5 heads of the indicated genotypes (mean±s.e.m.): control, 1246±46, n=6; Vegfa120/120, 854±21,
n=5; Vegfa188/188, 1335±63, n=3; Vegfa120/188, 1314±58, n=3; t-test; ***P<0.001 compared with control.
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Hindbrain explants were cultured as previously described (Schwarz et al.,
2004; Tillo et al., 2014). Affi-Gel heparin beads (Bio-Rad) were soaked
overnight in 100 ng/ml of VEGF164 in PBS (Preprotech) or VEGF188
(Reliatech). FBM neuron migration was measured with ImageJ (NIH) as the
distance travelled from r5 to the leading group of cells in r6 in each hindbrain
and normalised to the control side of each hindbrain.
DiI labelling
DiI labelling was performed with fixed tissues as described previously
(Erskine et al., 2011). Briefly, a DiI crystal (Life Technologies) was placed
over the optic disc of one eye for anterograde labelling. After 3 days at 37°C,
dissected brains were imaged ventral side upwards. ImageJ was used to
determine the pixel intensity in defined areas of the ipsilateral and
contralateral optic tracts, and the ipsilateral index calculated as the ratio of
fluorescent intensity in the ipsilateral relative to the ipsilateral plus
contralateral tracts. For retrograde labelling, the cortex was removed
unilaterally and DiI crystals placed in a row over the dorsal thalamus for
15 weeks at room temperature; we imaged flatmounted retinas as above and
determined the percentage of labelled ipsilateral RGCs relative to the
ipsilateral plus contralateral RGCs.
GnRH neuron analysis and survival assays
Immunolabelled GnRH-positive cells were quantitated and GN11 survival
assays performed as described previously (Cariboni et al., 2011). For
survival assays, cells were serum starved for 72 h and treated for 12 h with
media containing 10% FBS, 10 ng/ml VEGF120, VEGF164 or VEGF188.
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